Aardvark Therapeutics appoints David Zhang to board
Aardvark Therapeutics said it appointed David Zhang, Ph.D., MBA, to its board of directors effective Oct. 7, 2026. The company said he will serve as an independent director.
Aardvark Therapeutics said it appointed David Zhang, Ph.D., MBA, to its board of directors effective Oct. 7, 2026. The company said he will serve as an independent director.